Grey Sky Venture Partners
7
1M
3
0.88
1
- Stages of investment
- Areas of investment
Summary
The main office of represented VC is situated in the Bellevue. The fund was located in North America if to be more exact in United States.
The overall number of key employees were 3.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. The fund has exact preference in some founders of portfolio startups. Among the most successful fund investment fields, there are Medical Device, mHealth. Among the most popular portfolio startups of the fund, we may highlight Sonavex, Biolinq, Altoida.
When the investment is from Grey Sky Venture Partners the average startup value is 10-50 millions dollars. The usual things for fund are deals in the range of 5 - 10 millions dollars. The important activity for fund was in 2019. The fund is generally included in 2-6 deals every year. Speaking about the real fund results, this VC is 13 percentage points more often commits exit comparing to other organizations.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Grey Sky Venture Partners, startups are often financed by VI Partners AG, Fyrfly Venture Partners, Alpana Ventures. The meaningful sponsors for the fund in investment in the same round are Mitsubishi UFJ Capital, M Ventures, Hikma Ventures. In the next rounds fund is usually obtained by National Institutes of Health, Pangaea Ventures, National Science Foundation.
Investments analytics
Analytics
- Total investments
- 7
- Lead investments
- 1
- Rounds per year
- 0.88
- Investments by industry
- Medical (2)
- Biotechnology (2)
- Therapeutics (2)
- Augmented Reality (1)
- Medical Device (1) Show 8 more
- Investments by region
-
- United States (2)
- Canada (1)
- Peak activity year
- 2019
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 8
- Avg. valuation at time of investment
- 4M
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| HepaTx | 20 Aug 2018 | Biotechnology, Medical, Therapeutics | Seed | 2M | United States, California, Palo Alto |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.